Home › Funds › Millennium Management › BOLT
Millennium Management position in BOLT
BOLT BIOTHERAPEUTICS INC · Health Care
Latest position (Q4 2024)47.02K sh
Reported value held$25.16K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 163.13K | $2.06M | New |
| Q2 2022 | 191.86K | $391.00K | New |
| Q3 2022 | 118.38K | $175.00K | Reduce |
| Q4 2022 | 243.40K | $316 | Add |
| Q1 2023 | 245.41K | $341 | Add |
| Q2 2023 | 113.99K | $145.91K | Reduce |
| Q3 2023 | 44.98K | $46.78K | Reduce |
| Q4 2023 | 47.01K | $52.65K | Add |
| Q1 2024 | 45.96K | $64.34K | Reduce |
| Q4 2024 | 47.02K | $25.16K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BOLT
- Renaissance Technologies 98.62K sh · $379.71K · Q2 2026
- Citadel Advisors 56.90K sh · $219.08K · Q2 2026
- Geode Capital Management 19.12K sh · $73.62K · Q2 2026
- Vanguard Group 10.18K sh · $55.78K · Q4 2025
- BlackRock Inc 9.71K sh · $37.39K · Q2 2026
- Morgan Stanley 3.15K sh · $12.11K · Q2 2026
- UBS Group AG 255 sh · $982 · Q2 2026
- JPMorgan Chase & Co 42 sh · $165 · Q2 2026
- Citigroup Inc 41 sh · $158 · Q2 2026